LGK-974: Precision PORCN Inhibition for Advanced Wnt-Driv...
2025-10-18
Explore how LGK-974, a potent and specific PORCN inhibitor, is transforming Wnt-driven cancer research through unparalleled selectivity and innovative mechanistic insights. This article uniquely examines LGK-974’s advanced applications in challenging cancer models and its synergy with emerging therapeutic strategies.